Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIN457 versus placebo in relapsing-remitting multiple sclerosis
2009-011626-34Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in relapsing-remitting multiple sclerosis (RRMS) comparing AIN457 with Placebo (2 arms). Started Jul 2009; status: completed.
02
Drugs
secukinumab
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on 2009-011626-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011626-34.